Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Clasificación en acciones #38575
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Precio por acción
$1.48
Capitalización bursátil
$883.58K
Cambio (1 día)
-1.99%
Cambio (1 año)
-88.89%
País
US
Comercio Enveric Biosciences, Inc. (ENVB)

Categoría

Historial del precio de la acción de Enveric Biosciences, Inc. (ENVB)
Precio más alto de cierre: $1.53 el 2026-08-01

Precio más bajo de cierre: $4.75M el 2005-12-01
Historial del precio de la acción de Enveric Biosciences, Inc. desde 2005 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -15.21%
2025 -91.07%
2024 -76.28%
2023 -38.51%
2022 -95.86%
2021 -83.62%
2020 -22.41%
2019 -58.83%
2018 -91.51%
2017 -49.55%
2016 -1.21%
2015 416.23%
2014 5.31%
2013 356.80%
2012 -76.68%
2011 39.62%
2010 43.94%
2009 -80.84%
2008 -55.69%
2007 72.79%
2006 -43.88%
2005 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$508.06 30.17%
US
$849.76 30.25%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE